{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:03:49Z","timestamp":1790211829687,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.schres.2017.08.006","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T06:16:14Z","timestamp":1502259374000},"page":"480-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Increased prevalence of Toxoplasma gondii seropositivity in patients with treatment-resistant schizophrenia"],"prefix":"10.1016","volume":"193","author":[{"given":"Suzana","family":"Vlatkovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Sagud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6200-2405","authenticated-orcid":false,"given":"Dubravka","family":"Svob Strac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Sviben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Zivkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Vilibic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjanka","family":"Vuksan-Cusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Mihaljevic-Peles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nela","family":"Pivac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2017.08.006_bb0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.psychres.2013.06.042","article-title":"Differential cognitive performances between schizophrenic responders and nonresponders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses","volume":"210","author":"de Bartolomeis","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2017.08.006_bb0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.psychres.2016.08.056","article-title":"Toxoplasma gondii infection in schizophrenia and associated clinical features","volume":"245","author":"Esshili","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2017.08.006_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12888-016-1177-y","article-title":"Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? A systematic review","volume":"17","author":"Gillespie","year":"2017","journal-title":"BMC Psychiatry."},{"issue":"4","key":"10.1016\/j.schres.2017.08.006_bb0020","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.PFS-0011-2015","article-title":"Toxoplasma gondii as a parasite in food: analysis and control","volume":"4","author":"Hill","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.schres.2017.08.006_bb0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/pim.12157","article-title":"Toxoplasma gondii-induced neuronal alterations","volume":"37","author":"Parlog","year":"2015","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.schres.2017.08.006_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/acps.12423","article-title":"Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis","volume":"132","author":"Sutterland","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2017.08.006_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2012.02.013","article-title":"Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation","volume":"197","author":"Suzuki","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2017.08.006_bb0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.comppsych.2012.07.002","article-title":"The role of ethnicity in treatment refractory schizophrenia","volume":"54","author":"Teo","year":"2013","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2017.08.006_bb0045","first-page":"19","article-title":"Occurrence of Toxoplasma gondii antibodies in the population of Split-Dalmatia County","volume":"124","author":"Tonkic","year":"2002","journal-title":"Lijec. Vjesn."},{"key":"10.1016\/j.schres.2017.08.006_bb0050","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.schres.2016.03.021","article-title":"Inverse association between urbanicity and treatment resistance in schizophrenia","volume":"174","author":"Wimberley","year":"2016","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417304723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417304723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T22:28:17Z","timestamp":1659306497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417304723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":10,"alternative-id":["S0920996417304723"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.08.006","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased prevalence of Toxoplasma gondii seropositivity in patients with treatment-resistant schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}